View source for Blastomycosis

{{hatnote|Not to be confused with [[chromoblastomycosis]]. For "South American blastomycosis", see [[paracoccidioidomycosis]]. For "European blastomycosis", see [[cryptococcosis]].}}
{{Infobox medical condition (new)
| name            = Blastomycosis
| synonyms        = Blasto,<ref>{{Cite book| url = https://books.google.com/books?id=XS-CDwAAQBAJ&pg=PT160 | title = The Ultimate Hunting Dog Reference Book: A Comprehensive Guide to More Than 60 Sporting Breeds| author-first = Vickie| author-last = Lamb| publisher = Simon & Schuster| year = 2011| isbn = 9781634504621
 }}</ref> North American blastomycosis,<ref name=John2017/> Chicago disease<ref>{{Cite book| title =  Fungal Pathogenesis: Principles and Clinical Applications| first = Richard | last = Calderone | year = 2002| location = Boca Raton| publisher = CRC Press| doi = 10.1201/9781482270907| isbn = 9780429153228}}</ref>
| image           = Blastomycosis lung infiltration.png
| caption         = Lung infiltration in blastomycosis.
| pronounce       =
| field           = [[Infectious disease (medical specialty)|Infectious disease]]<ref name="ICD-11">{{cite web |title=ICD-11 – ICD-11 for Mortality and Morbidity Statistics |url=https://icd.who.int/browse11/l-m/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f1968108845|website=icd.who.int |access-date=29 May 2021}}</ref>
| symptoms        =*Lungs: [[fever]], [[cough]], [[night sweats]], [[myalgia|muscle pains]], weight loss, chest pain, [[fatigue (medical)|fatigue]]<ref name=Symptoms/> 
*Skin: crusting purplish warty plaques with a roundish [[pustule|bumpy]] edge and central depression<ref name=John2017/>
| complications   =
| onset           =
| duration        =
| types           =
| causes          =''[[Blastomyces dermatitidis]]''<ref name=John2017/>
| risks           =
| diagnosis       =
| differential    =
| prevention      =
| treatment       = [[Antifungals]]<ref name="CDC HP"/>
| medication      = [[Itraconazole]], [[amphotericin B]]<ref name="CDC HP"/>
| prognosis       =
| frequency       =
| deaths          =
}}
<!-- Definition and symptoms -->
'''Blastomycosis''', also known as '''Gilchrist's disease''', is a [[fungal infection]], typically of the [[lungs]], which can spread to [[brain]], [[gastrointestinal tract|stomach, intestine]] and [[skin]], where it appears as crusting purplish warty plaques with a roundish [[pustule|bumpy]] edge and central depression.<ref name=John2017>{{cite book|last=Johnstone |first=Ronald B.|title=Weedon's Skin Pathology Essentials |chapter-url=https://books.google.com/books?id=NTE_DAAAQBAJ&pg=PA449|year=2017|publisher=Elsevier |edition=2nd|isbn=978-0-7020-6830-0|pages=449|chapter=25. Mycoses and Algal infections}}</ref><ref name=CDC>{{Cite web| url = https://www.cdc.gov/fungal/diseases/blastomycosis/index.html| title = Blastomycosis| website = cdc.gov| date = 9 February 2022| accessdate = 2022-05-14| publisher = Centers for Disease Control and Prevention}}</ref> Around half of the people with the disease have symptoms, which can include [[fever]], [[cough]], [[night sweats]], [[myalgia|muscle pains]], weight loss, chest pain, and [[fatigue]].<ref name="Symptoms">{{cite web| url = https://www.cdc.gov/fungal/diseases/blastomycosis/symptoms.html| title = Symptoms of Blastomycosis| author = <!--Not stated-->| website = cdc.gov | archive-url = https://web.archive.org/web/20190426023508/https://www.cdc.gov/fungal/diseases/blastomycosis/symptoms.html| archive-date = 26 April 2019| url-status = live| access-date = 15 May 2019| date = 2019-01-29 }}</ref> Symptoms usually develop between three weeks and three months after breathing in the spores.<ref name="Symptoms"/> In 25% to 40% of cases, the infection also spreads to other parts of the body, such as the skin, bones, or [[central nervous system]].<ref name="mcbride2017">{{Cite journal| journal = Clinics in Chest Medicine| date = September 2017| volume = 38 | issue = 3| pages = 435–449| doi = 10.1016/j.ccm.2017.04.006| title = Clinical manifestations and treatment of blastomycosis| author1-first = Joseph A.| author1-last = McBride| author2-first = Gregory M.| author2-last = Gauthier| author3-first = Bruce S.| author3-last = Klein| pmid = 28797487| pmc = 5657236}}</ref> Although blastomycosis is especially dangerous for those with [[immunodeficiency|weak immune systems]], most people diagnosed with blastomycosis have healthy immune systems.<ref name="mcbride2017"/>

<!-- Prevention and treatment -->
''Blastomyces dermatitidis'' is found in the soil and decaying organic matter like wood or leaves.<ref name="CDC HP">{{cite web | url = https://www.cdc.gov/fungal/diseases/blastomycosis/health-professionals.html#four | title = Information for Healthcare Professionals about Blastomycosis | author = <!--Not stated--> | website = cdc.gov | archive-url = https://web.archive.org/web/20190426025156/https://www.cdc.gov/fungal/diseases/blastomycosis/health-professionals.html | archive-date = 26 April 2019 | url-status = live | access-date = 15 May 2019 | date = 2019-01-24 }}</ref> Outdoor activities like hunting or camping in wooded areas increase the risk of developing blastomycosis.<ref name=Prevention>{{cite web | url = https://www.cdc.gov/fungal/diseases/blastomycosis/risk-prevention.html | title = Blastomycosis Risk & Prevention | author = <!--Not stated--> | website = cdc.gov | archive-url = https://web.archive.org/web/20190426023512/https://www.cdc.gov/fungal/diseases/blastomycosis/risk-prevention.html | archive-date = 26 April 2019 | url-status = live | access-date = 22 May 2019 | date = 2019-01-29 }}</ref> There is no vaccine, but the risk of the disease can be reduced by not disturbing the soil.<ref name=Prevention/> Treatment is typically with an azole drug such as [[itraconazole]] for mild or moderate disease.<ref name="idsa2008"/> In severe cases, patients are treated with [[amphotericin B]] before azole treatment.<ref name="idsa2008"/> In either event, the azole treatment lasts for 6–12 months.<ref>{{cite web | url = https://www.cdc.gov/fungal/diseases/blastomycosis/treatment.html | title = Treatment for Blastomycosis | author = <!--Not stated--> | website = cdc.gov | archive-url = https://web.archive.org/web/20190426025257/https://www.cdc.gov/fungal/diseases/blastomycosis/treatment.html | archive-date = 26 April 2019 | url-status = live | access-date = 22 May 2019 | date = 2019-01-29 }}</ref> Overall, 4–6% of people who develop blastomycosis die; however, if the central nervous system is involved, this rises to 18%. People with [[AIDS]] or on [[Immunosuppressive drug|medications that suppress the immune system]] have the highest risk of death at 25–40%.<ref>{{cite journal | vauthors = Castillo CG, Kauffman CA, Miceli MH | title = Blastomycosis | journal = Infectious Disease Clinics of North America | volume = 30 | issue = 1 | pages = 247–64 | date = March 2016 | pmid = 26739607 | doi = 10.1016/j.idc.2015.10.002}}</ref>

<!-- Epidemiology and history -->
Blastomycosis is [[Endemic (epidemiology)|endemic]] to the eastern United States and Canada, especially the Ohio and Mississippi River valleys, the Great Lakes, and the St. Lawrence River valley.<ref name="CDC HP"/> In these areas, there are about 1 to 2 cases per 100,000 per year.<ref>{{cite web | url = https://www.cdc.gov/fungal/diseases/blastomycosis/statistics.html | title = Blastomycosis Statistics | author = <!--Not stated--> | website = cdc.gov | archive-url = https://web.archive.org/web/20190426023947/https://www.cdc.gov/fungal/diseases/blastomycosis/statistics.html | archive-date = 26 April 2019 | url-status = live | access-date = 22 May 2019 | date = 2019-01-24 }}</ref> Less frequently, blastomycosis also occurs in Africa, the Middle East, India, and western North America.<ref name="mcbride2017"/><ref name="schwartz2021"/> Blastomycosis also affects a broad range of non-human mammals, and dogs in particular are an order of magnitude more likely to contract the disease than humans.<ref name="schwartz2018"/> The ecological niche of ''Blastomyces'' in the wild is poorly understood, and it is unknown if there are any significant host animals.<ref name="baumgardner2016">{{Cite journal
 | author1-last = Baumgardner
 | author1-first = Dennis J.
 | title = Blastomyces: Why be dimorphic?
 | journal = Journal of Patient-Centered Research and Reviews
 | year = 2016
 | volume = 3
 | issue = 2
 | pages = 61–63
 | doi = 10.17294/2330-0698.1256
| doi-access = free
 }}</ref>

Blastomycosis has existed for millions of years but was first described by [[Thomas Caspar Gilchrist]] in 1894. Because of this, it is sometimes called "Gilchrist's disease".<ref name=Gilchrist>{{cite book | last1 = Crissey | first1 = John Thorne | last2 = Parish | first2 = Lawrence C. | last3 = Holubar | first3 = Karl  | title = Historical Atlas of Dermatology and Dermatologists | url = https://books.google.com/books?id=7ThZDwAAQBAJ&q=Thomas+Casper+Gilchrist&pg=PA86 | year = 2002 | publisher = Parthenon Publishing Group | pages = 86 | isbn = 978-1842141007 }}</ref>

==Signs and symptoms==
[[File:An introduction to dermatology (1905) blastomycosis.jpg|thumb|Skin lesions caused by blastomycosis.]]
The symptoms of blastomycosis cover a wide range, overlapping with more common conditions; for this reason, blastomycosis has often been called "the great pretender".<ref name="mcbride2017"/> Many cases are [[asymptomatic]] or subclinical. Lung symptoms are common because the lungs are infected in 79% of blastomycosis cases.<ref name="mcbride2017"/> However, in 25–40% of cases, the disease also disseminates to other organs, including the skin.<ref name="mcbride2017"/>

The extent and severity of symptoms depend in part on a person's immune status; less than 50% of healthy people with blastomycosis have symptoms, while immunocompromised patients are especially likely to have the disease spread beyond the lungs to other organs like the skin and bones.<ref name="Murray 2015">{{cite book | vauthors = Murray P, Rosenthal K, Pfaller M | year = 2015 | chapter = Chapter 64: Systemic Mycoses Caused by Dimorphic Fungi | title = Medical Microbiology | edition = 8 | publisher = Elsevier | pages = 629–633 | isbn = 978-0323299565 }}</ref>

Blastomycosis manifests as a primary [[lung]] infection in about 79% of cases.<ref name="mcbride2017"/> The onset is relatively slow, and symptoms are suggestive of bacterial pneumonia, often leading to initial treatment with antibacterials. Because the symptoms are variable and nonspecific, blastomycosis is often not even considered in [[differential diagnosis]] until antibacterial treatment has failed, unless there are known risk factors or skin lesions.<ref name="mcbride2017"/> The disease may be misdiagnosed as a carcinoma, leading in some cases to surgical removal of the affected tissue.<ref>{{Cite journal
  | journal = Transactions of the American Clinical and Climatological Association
  | year = 2014
  | volume = 125
  | pages = 188–203
  | pmc = 4112704
  | pmid = 25125734
  | title = The Endemic Mimic: Blastomycosis An Illness Often Misdiagnosed
  | author-first = Robert W. 
  | author-last = Bradsher
}}</ref> Upper lung lobes are involved somewhat more frequently than lower lobes.<ref name=kwonchung1992/> If untreated, many cases progress over months to years to become disseminated blastomycosis.

Blastomycosis in the lungs may present a variety of symptoms, or no symptoms at all.<ref name="mcbride2017"/> If symptoms are present they may range from mild [[pneumonia]] resembling a [[pneumococcal]] infection to [[ARDS|acute respiratory distress syndrome (ARDS)]].<ref name="mcbride2017"/> Common symptoms include fever, chills, headache, coughing, difficulty breathing, chest pain, and malaise.<ref name="mcbride2017"/> Without treatment, cases may progress to chronic pneumonia or ARDS.<ref name="mcbride2017"/>

ARDS is an uncommon but dangerous manifestation of blastomycosis. It was seen in 9 of 72 blastomycosis cases studied in northeast Tennessee.<ref name="vasquez1998"/> Such cases may follow massive exposure, such as during brush clearing operations. In the Tennessee study, the fatality rate was 89% in the ARDS cases, but only 10% in the non-ARDS cases.<ref name="vasquez1998"/>

In disseminated blastomycosis, the large ''Blastomyces'' yeast cells translocate from the lungs and are trapped in capillary beds elsewhere in the body, where they cause lesions. The skin is the most common organ affected, being the site of lesions in approximately 60% of cases.<ref name=kwonchung1992/> The signature image of blastomycosis in textbooks is the [[Indolent condition|indolent]], verrucous or ulcerated dermal lesion seen in disseminated disease. [[Osteomyelitis]] is also common (12–60% of cases). Other recurring sites of dissemination are the genitourinary tract (kidney, prostate, epididymis; collectively ca. 25% of cases) and the brain (3–10% of cases).<ref name=kwonchung1992/>  Among immunocompromised individuals, 40% have [[Central nervous system|CNS]] involvement presenting as [[brain abscess]], epidural abscess or [[meningitis]].{{citation needed|date=December 2024}}

Blastomycosis in non-lung organs, such as the skin, may present a very wide range of symptoms, including the following:
* skin lesions, which may be verrucous (wart-like) or ulcerated with small pustules at the margins.
* bone or joint pain due to bone lytic lesions.
* pain when urinating due to [[prostatitis]].
* hoarseness due to [[larynx|laryngeal]] involvement.
* headache, confusion or other neurological symptoms caused by [[central nervous system]] involvement.

==Cause==

Blastomycosis is caused by [[Dimorphic fungus|dimorphic fungi]] in the genus ''Blastomyces'', in the phylum [[Ascomycota]] and family [[Ajellomycetaceae]]. In eastern North America, the most common cause of blastomycosis is ''[[Blastomyces dermatitidis]]'', but ''[[Blastomyces gilchristii]]'' has been associated with some outbreaks. In western North America, many cases of blastomycosis are caused by ''[[Blastomyces helicus]]'', which most commonly attacks immunodeficient people and domestic animals. The species ''[[Blastomyces percursus]]'' causes many cases of blastomycosis in Africa and the Middle East.<ref name="schwartz2021">{{Cite journal
 | title = Blastomycosis in Africa and the Middle East: A Comprehensive Review of Reported Cases and Reanalysis of Historical Isolates Based on Molecular Data
 | author1-first = Ilan S
 | author1-last = Schwartz
 | display-authors=etal
 | journal = Clinical Infectious Diseases
 | volume = 73
 | issue = 7
 | date = 2021-10-01
 | pages = e1560–e1569
 | doi = 10.1093/cid/ciaa1100
 | pmid = 32766820
 | pmc = 8492124
 | url = https://academic.oup.com/cid/article/73/7/e1560/5885166
 | accessdate = 2022-05-14
}}</ref> In Africa, blastomycosis may also be caused by ''[[Blastomyces emzantsi]]'', which is often associated with infections outside the lungs.<ref>{{Cite journal
 | title = Name Changes for Fungi of Medical Importance, 2018 to 2019
 | author1-first = Andrew M.
 | author1-last = Borman
 | author2-first = Elizabeth M.
 | author2-last = Johnson
 | journal = Journal of Clinical Microbiology
 | date = February 2021
 | volume = 59
 | issue = 2
 | pages = e01811–20
 | doi = 10.1128/JCM.01811-20
 | pmid = 33028600
 | pmc = 8111128
 }}</ref>

In endemic areas, ''Blastomyces dermatitidis'' lives in soil and rotten wood near lakes and rivers. Although it has never been directly observed growing in nature, it is thought to grow there as a cottony white mold, similar to the growth seen in artificial culture at 25&nbsp;°C. The moist, acidic soil in the surrounding woodland harbors the fungus.

==Pathogenesis==
[[Image:Blastomyces dermatitidis GMS.jpeg|thumb|Large, broadly-based budding yeast cells characteristic of ''Blastomyces dermatitidis'' in a GMS-stained biopsy section from a human leg.]]

Inhaled conidia of ''Blastomyces'' are [[phagocytosed]] by neutrophils and macrophages in alveoli. Some of these escape phagocytosis and transform into the yeast phase rapidly. Having thick walls, these are resistant to phagocytosis. Once they have transitioned to the yeast phase, the ''Blastomyces'' cells express the protein ''BAD-1'', which helps the yeast cells attach to host cells, and also impairs the activation of immune cells while inhibiting the release of [[tumor necrosis factor]].
<ref>{{Cite journal
  | title = Turning on virulence: Mechanisms that underpin the morphologic transition and pathogenicity of ''Blastomyces''
  | journal = Virulence
  | volume = 10
  | year = 2019
  | issue = SI2
  | author1-first = Joseph A. 
  | author1-last = McBride
  | author2-first = Gregory M. 
  | author2-last = Gauthier
  | author3-first = Bruce S. 
  | author3-last = Klein
  | pages = 801–809
| doi = 10.1080/21505594.2018.1449506
 | pmid = 29532714
 | pmc = 6779398
  }}</ref> In lung tissue, the cells multiply and may also disseminate through blood and [[lymphatics]] to other organs, including the skin, bone, genitourinary tract, and brain. The incubation period for pulmonary blastomycosis is 3 to 15 weeks, although 30–50% of infections are asymptomatic.<ref name="khuu-2014">{{Cite journal
  | author1-first = Diana 
  | author1-last = Khuu
  | display-authors = etal
  | date = November 2014
  | title = Blastomycosis Mortality Rates, United States, 1990–2010
  | journal = Emerging Infectious Diseases 
  | volume = 20
  | issue = 11
  | pages = 1789–1794
  | doi = 10.3201/eid2011.131175
  | pmc = 4214285
  | pmid = 25339251
}}</ref>

==Diagnosis==
Because the symptoms of blastomycosis resemble those of many other conditions, including [[tuberculosis]] and lung cancer, diagnosis is often delayed. In 40% of cases, the diagnosis takes more than a month.<ref name="mazi2021">{{Cite journal
 | journal = Infectious Disease Clinics of North America
 | volume = 35
 | issue = 2
 | date = June 2021
 | pages = 515–530
 | title = Blastomycosis
 | author1-first = Patrick B.
 | author1-last = Mazi
 | author2-first = Adriana M.
 | author2-last = Rauseo
 | author3-first = Andrej
 | author3-last = Spec
| doi = 10.1016/j.idc.2021.03.013
 | pmid = 34016289
 | s2cid = 235074776
 }}</ref> A rapid diagnosis can, however, be made based on microscopic examination of [[sputum]] samples or samples obtained from a tissue [[biopsy]] or [[bronchoalveolar lavage]].<ref name="nel2018">{{Cite journal
 | journal =  Infectious Disease Clinics of North America
 | author1 = Nel, J. S.
 | author2 = Bartelt, L. A.
 | author3 = van Duin, D.
 | author4 = Lachiewicz, A. M.
 | year = 2018
 | title = Endemic Mycoses in Solid Organ Transplant Recipients
 | volume = 32
 | issue = 3
 | pages = 667–685
 | doi = 10.1016/j.idc.2018.04.007
| pmid = 30146029
 | pmc = 6230265
 }}</ref>

Once suspected, the diagnosis of blastomycosis can usually be confirmed by demonstration of the characteristic broad-based budding organisms in sputum or tissues by [[KOH test|KOH prep]], cytology, or histology.<ref name="veligandla2002"/> Tissue biopsy of the skin or other organs may be required to diagnose extra-pulmonary disease. Blastomycosis is histologically associated with granulomatous nodules.

Commercially available urine antigen testing appears to be quite sensitive in suggesting the diagnosis in cases where the organism is not readily detected.<ref name="nel2018"/> However, commercial antigen tests have a high degree of [[cross-reactivity]] with other endemic fungal conditions such as [[histoplasmosis]], and thus cannot distinguish blastomycosis from other similar conditions.<ref name="nel2018"/><ref name="linder2021">{{Cite journal
 | title = Current and New Perspectives in the Diagnosis of Blastomycosis and Histoplasmosis
 | author1-first = Kathleen A.
 | author1-last = Linder
 | author2-first = Carol A.
 | author2-last = Kauffman
 | journal = Journal of Fungi
 | year = 2021
 | volume = 7
 | issue = 1
 | page = 12
 | doi = 10.3390/jof7010012| pmid = 33383637
 | pmc = 7823406
 | doi-access = free
 }}</ref>  This cross-reactivity is caused by these related fungal organisms using similar [[galactomannan]]s in the [[cell wall]].<ref name="linder2021"/>

While a culture of the ''Blastomyces'' organism remains the definitive diagnostic standard, its slow-growing nature can lead to a delay of up to four weeks.<ref name="mazi2021"/> In addition, sometimes blood and sputum cultures may not detect blastomycosis.<ref>{{Cite journal|last1=Morgan|first1=Matthew W|last2=Salit|first2=Irving E|date=1996|title=Human and canine blastomycosis: A common source infection|journal=The Canadian Journal of Infectious Diseases|volume=7|issue=2|pages=147–151|issn=1180-2332|pmc=3327387|pmid=22514432|doi=10.1155/1996/657941|doi-access=free}}</ref> Cultures of the [[cerebrospinal fluid]] also have poor sensitivity compared to [[histopathology|histopathological]] examination of the affected tissue.<ref>{{Cite journal
 | author1 = Majdick, K.
 | author2 = Kaye, K.
 | author3 = Shorman, M. A.
 | year = 2020
 | title = Central nervous system blastomycosis clinical characteristics and outcomes
 | journal = Medical Mycology
 | volume = 59
 | issue = 1
 | pages = 87–92
 | doi = 10.1093/mmy/myaa041
| pmid = 32470976
 }}</ref>

== Treatment ==

Under [[Infectious Disease Society of America]] guidelines, severe cases of blastomycosis and cases with central nervous system (CNS) involvement are treated initially with [[amphotericin B]], followed by a lengthy course of an azole drug such as [[itraconazole]].<ref name="idsa2008">{{Cite journal
 | title =  Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America
 | author1-first = Stanley W.
 | author1-last = Chapman
 | author2-first = William E.
 | author2-last = Dismukes
 | author3-first = Laurie A.
 | author3-last = Proia
 | author4-first = Robert W.
 | author4-last = Bradsher
 | author5-first = Peter G.
 | author5-last = Pappas
 | author6-first = Michael G.
 | author6-last = Threlkeld
 | author7-first = Carol A.
 | author7-last = Kauffman
 | journal = Clinical Infectious Diseases
 | volume = 46
 | issue = 12
 | date = 2008-06-15
 | pages = 1801–1812
 | doi = 10.1086/588300
| pmid = 18462107
 | doi-access = free
 }}</ref> In most cases the amphotericin treatment lasts for 1–2 weeks, but in cases of CNS involvement it may last for up to 6 weeks.<ref name="idsa2008"/> Cases that do not require amphotericin B treatment are treated with a lengthy course of an azole drug.<ref name="idsa2008"/>

Among azole drugs, [[itraconazole]] is generally the treatment of choice. [[Voriconazole]] is often recommended for CNS blastomycosis cases due to its ability to pass the [[blood–brain barrier]].<ref name="idsa2008"/> Other azole drugs that may be used include [[fluconazole]]. [[Ketoconazole]] was the azole drug first used for blastomycosis treatment, but has been largely replaced by itraconazole because ketoconazole is less effective and less tolerated by patients.<ref name="idsa2008"/> The azole treatment generally lasts for a minimum of six months. Cure rates from itraconazole treatment are nearly 95%.<ref name="idsa2008"/> [[Relapse]] is rare but does occur even after a full course of treatment.<ref name="idsa2008"/>

== Prognosis ==

Published estimates of the [[case fatality rate]] for blastomycosis have varied from 4% to 78%.<ref name="carignan-2020">{{Cite journal
  | author1-first = Alex 
  | author1-last = Carignan
  | author2-first = Mélina 
  | author2-last = Denis
  | author3-first = Claire Nour 
  | author3-last = Abou Chakra
  | date = January 2020
  | title = Mortality associated with Blastomyces dermatitidis infection: A systematic review of the literature and meta-analysis
  | journal = Medical Mycology
  | publisher = Oxford Academic
  | volume = 58
  | issue = 1
  | pages = 1–10
  | doi = 10.1093/mmy/myz048
  | pmid = 31111911
 | url =  https://academic.oup.com/mmy/article-abstract/58/1/1/5492543
  | access-date = 2022-07-07
| url-access = subscription
  }}</ref> A 2020 meta-analysis of published studies found an overall mortality rate of 6.6%.<ref name="carignan-2020"/> This rose to 37% for immunocompromised patients and 75% for patients with ARDS.<ref name="carignan-2020"/> A 2021 analysis of 20 years of [[disease surveillance]] data from the five US states where blastomycosis is [[notifiable disease|reportable]] found an overall mortality rate of 8% and a hospitalization rate of 57%.<ref name="benedict-2021">{{Cite journal
  | author1-first = Kaitlin 
  | author1-last = Benedict
  | display-authors = et al 
  | date = April 2021
  | title = Blastomycosis Surveillance in 5 States, United States, 1987–2018
  | journal = Emerging Infectious Diseases 
  | volume = 27
  | issue = 4
  | pages = 999–1006
  | doi = 10.3201/eid2704.204078 
  | pmc = 8007286
  | pmid = 33757624
  }}</ref> These numbers may be affected by the under-reporting of mild cases.<ref name="benedict-2021"/>

== Epidemiology ==
[[Image:Blasto-map 600.jpg|thumb|Distribution of blastomycosis in North America based on the map given by Kwon-Chung and Bennett,<ref name=kwonchung1992/> with modifications made according to case reports from a series of additional sources.<ref name=crampton2002/><ref name=dwight2000/><ref name=kane1983/><ref name=lester2000/><ref name=morris2006/><ref name=sekhon1982/><ref name=vallabh1988/>]]
Incidence in most endemic areas is about 0.5 per 100,000 population, with occasional local areas attaining as high as 12 per 100,000.<ref name=kwonchung1992/><ref name=rippon1988/><ref name=manetti1991/><ref name=cano2003/> Most Canadian data fit this picture. In Ontario, Canada, considering both endemic and non-endemic areas, the overall incidence is around 0.3 cases per 100,000; northern Ontario, mostly endemic, has 2.44 per 100,000.<ref name=morris2006/> [[Manitoba]] is calculated at 0.62 cases per 100,000.<ref name=crampton2002/> Remarkably higher incidence was shown for the [[Kenora, Ontario]] region: 117 per 100,000 overall, with Aboriginal reserve communities experiencing 404.9 per 100,000.<ref name=dwight2000/> In the United States, the incidence of blastomycosis is similarly high in hyperendemic areas. For example, the city of Eagle River, Vilas County, Wisconsin, has an incidence rate of 101.3 per 100,000; the county as a whole has been shown in two successive studies to have an incidence of about 40 cases per 100,000.<ref name=baumgardner1998/> An incidence of 277 per 100,000 was roughly calculated based on 9 cases seen in a Wisconsin aboriginal reservation during a time in which extensive excavation was done for new housing construction.<ref name=baumgardner2002/> The new case rates are greater in northern states such as [[Wisconsin]], where from 1986 to 1995 there were 1.4 cases per 100,000 people.<ref name=mmwr1996/>

The study of outbreaks as well as trends in individual cases of blastomycosis has clarified several important matters. Some of these relate to the ongoing effort to understand the source of the infectious inoculum of this species, while others relate to which groups of people are especially likely to become infected. Human blastomycosis is primarily associated with forested areas and open watersheds;<ref name=kwonchung1992/><ref name=disalvo1992/><ref name=baumgardner2005a/><ref name=baumgardner2006/> It primarily affects otherwise healthy, vigorous people, mostly middle-aged,<ref name=klein1987/> who acquire the disease while working or undertaking recreational activities in sites conventionally considered clean, healthy and in many cases beautiful.<ref name=kwonchung1992/><ref name=rippon1988/> Repeatedly associated activities include hunting, especially raccoon hunting,<ref name=armstrong1987/> where accompanying dogs also tend to be affected, as well as working with wood or plant material in forested or riparian areas,<ref name=kwonchung1992/><ref name=kesselman2005/> involvement in forestry in highly endemic areas,<ref name=vaaler1990/> excavation,<ref name=baumgardner1998/> fishing<ref name=klein1987/><ref name=baumgardner1992/> and possibly gardening and trapping.<ref name=dwight2000/><ref name=baumgardner1998/>

===Urban infections===
There is also a developing profile of urban and other domestic blastomycosis cases, beginning with an outbreak tentatively attributed to [[construction dust]] in [[Westmont, Illinois]].<ref name=kitchen1977/> The city of [[Rockford, Illinois]], was also documented as a hyperendemic area based on incidence rates as high as 6.67 per 100,000 population for some areas of the city. Though proximity to open watersheds was linked to incidence in some areas,<ref name=baumgardner2006/> suggesting that outdoor activity within the city may be connected to many cases, there is also an increasing body of evidence that even the interiors of buildings may be at-risk areas. An early case concerned a prisoner who was confined to prison during the whole of his likely blastomycotic incubation period.<ref name=renston1992/> An epidemiological survey found that although many patients who contracted blastomycosis had engaged in fishing, hunting, gardening, outdoor work, and excavation, the most strongly linked association in patients was living or visiting near waterways.<ref name=baumgardner1992/> Based on a similar finding in a Louisiana study, it has been suggested that place of residence might be the most important single factor in blastomycosis epidemiology in north central [[Wisconsin]].<ref name=lowry1989/> Follow-up epidemiological and case studies indicated that clusters of cases were often associated with particular domiciles, often spread out over years and that there were uncommon but regularly occurring cases in which pets kept mostly or entirely indoors, in particular cats, contracted blastomycosis.<ref name=blondin2007/><ref name=baumgardner2001/> The occurrence of blastomycosis, then, is an issue strongly linked to housing and domestic circumstances.

===Seasonal trends===
Seasonality and weather also appear to be linked to the contraction of blastomycosis. Many studies have suggested an association between blastomycosis contraction and cool to moderately warm, moist periods of the spring and autumn<ref name=kwonchung1992/><ref name=dwight2000/><ref name=rudmann1992/> or, in relatively warm winter areas.<ref name=arceneaux1998/> However, the entire summer or a known summer exposure date is included in the association in some studies.<ref name=klein1987/><ref name=archer1987/> Occasional studies fail to detect a seasonal link.<ref name=chapman1997/> In terms of weather, both unusually dry weather<ref name=proctor2002/> and unusually moist weather<ref name=degroote2000/> have been cited. The seemingly contradictory data can most likely be reconciled by proposing that ''B. dermatitidis'' prospers in its natural habitats in times of moisture and moderate warmth, but that inoculum formed during these periods remains alive for some time and can be released into the air by subsequent dust formation under dry conditions. Indeed, dust per se or construction potentially linked to dust has been associated with several outbreaks<ref name=vasquez1998/><ref name=kitchen1977/><ref name=baumgardner1991/> The data, then, tend to link blastomycosis to all weather, climate, and atmospheric conditions except freezing weather, periods of snow cover, and extended periods of hot, dry summer weather in which soil is not agitated.

===Gender bias===
Sex is another factor inconstantly linked to the contraction of blastomycosis: though many studies show more men than women affected,<ref name=kwonchung1992/><ref name=morris2006/> some show no sex-related bias.<ref name=dwight2000/><ref name=baumgardner1992/> As mentioned above, most cases are in middle-aged adults, but all age groups are affected, and cases in children are not uncommon.<ref name=kwonchung1992/><ref name=dwight2000/><ref name=morris2006/>

=== Ethnic populations ===

Ethnic group or race is frequently investigated in epidemiological studies of blastomycosis, but is potentially confounded by differences in residence, quality, and accessibility of medical care, factors that have not been stringently controlled to date. In the United States, some studies show a disproportionately high incidence and/or mortality rate for blastomycosis among [[Black people]].<ref name=manetti1991/><ref name=cano2003/><ref name=dworkin2005/><ref name=lemos2000/>

In Canada, some studies, but not others,<ref name=crampton2002/> indicate that [[First Nations in Canada|First Nations people]] have a disproportionately high incidence of blastomycosis.<ref name=dwight2000/><ref name=kepron1972/> Incidence in First Nations children may be unusually high.<ref name=dwight2000/> The Canadian data in some areas may be confounded or explained by the tendency to establish indigenous communities in wooded, riparian, northern areas corresponding to the core habitat of ''B. dermatitidis'', often with known ''B. dermatitidis'' habitats such as woodpiles and beaver constructions in the near vicinity.

===Communicability===
Blastomycosis is not considered contagious, either among humans or between animals and humans.<ref name="Prevention"/> However, there are a very small number of cases of human-to-human transmission of ''B. dermatitidis'' related to dermal contact<ref name=bachir2006/> or sexual transmission of disseminated blastomycosis of the genital tract among spouses.<ref name=kwonchung1992/>

== History ==
[[File:Thomas Caspar Gilchrist.jpg|thumb|Thomas Caspar Gilchrist, first describer of blastomycosis and ''Blastomyces dermatitidis''.]]
The organisms causing blastomycosis have existed for millions of years. The pathogenic group of [[onygenalean]] fungi that give rise to conditions including blastomycosis and histoplasmosis emerged approximately 150 million years ago.<ref name="caballerovandyke-2019">{{Cite journal
 | journal = Current Opinion in Microbiology
 | volume = 52
 | date = December 2019
 | pages = 55–63
 | author1-first = Marley C
 | author1-last = Caballero Van Dyke
 | author2-first = Marcus M
 | author2-last = Teixeira
 | author3-first = Bridget M
 | author3-last = Barker
 | title = Fantastic yeasts and where to find them: the hidden diversity of dimorphic fungal pathogens
 | doi = 10.1016/j.mib.2019.05.002
| pmid = 31181385
 | s2cid = 184486499
 | pmc = 11227906
 }}</ref> The most closely related blastomycosis-causing fungi, ''Blastomyces dermatitidis'' and ''Blastomyces gilchristii'', diverged during the [[Pleistocene]], approximately 1.9 million years ago.<ref name="klein2021">{{Cite book
 | title = Encyclopedia of Mycology
 | volume = 1
 | year = 2021
 | pages = 638–653
 | chapter = Blastomyces and Blastomycosis
 | author1-first = Bruce S.
 | author1-last = Klein
 | author2-first = Joseph A.
 | author2-last = McBride
 | author3-first = Gregory M.
 | author3-last = Gauthier
 | doi = 10.1016/B978-0-12-809633-8.21010-8
| isbn = 9780323851800
 | s2cid = 226502536
 }}</ref>

At the [[Koster Site]] in Illinois, evidence pointing to possible blastomycosis infections among [[Woodland period|Late Woodland]] [[Native Americans in the United States|Native Americans]] has been identified. At that site, [[Jane E. Buikstra|Dr. Jane Buikstra]] found evidence for what may have been an epidemic of a serious spinal disease in adolescents and young adults. Several of the skeletons showed lesions in the spinal vertebrae in the lower back. Two modern diseases produce lesions in the bone similar to the ones Dr. Buikstra found in these prehistoric specimens: [[Pott disease|spinal tuberculosis]] and blastomycosis. The bony lesions in these two diseases are practically identical. Blastomycosis seems more probable as these young people in Late Woodland and Mississippian times may have been affected because they were spending more time cultivating plants than their Middle Woodland predecessors had done. If true, it would be another severe penalty Late Woodland people had to pay as they shifted to agriculture as a way of life, and it would be a contributing factor to shortening their lifespans compared to those of the Middle Woodland people.<ref>Struever, Stuart and Felicia Antonelli Holton (1979). ''Koster: Americans in Search of Their Prehistoric Past''. New York: Anchor Press / Doubleday. {{ISBN|0-385-00406-0}}.</ref>

Blastomycosis was first described by [[Thomas Caspar Gilchrist]] in 1894, as a skin disease. Because of this, blastomycosis is sometimes called "Gilchrist's disease".<ref name=Gilchrist/> Gilchrist initially identified the cause of the disease as a [[protozoan]], but later correctly identified it as a fungus.<ref name="espinelingroff1996">{{Cite book
 | url = https://link.springer.com/book/10.1007/978-94-017-0311-6
 | doi = 10.1007/978-94-017-0311-6
 | author-first = Ana Victoria
 | author-last = Espinel-Ingroff
 | title = Medical Mycology in the United States: A Historical Analysis (1894–1996)
 | year = 2003
 | isbn = 978-94-017-0311-6| s2cid = 31440045
 }}</ref> In 1898, he and [[William Royal Stokes]] published the first description of ''Blastomyces dermatitidis''.<ref name="espinelingroff1996"/> Gilchrist referred to the disease as "blastomycetic dermatitis".

The systemic spread of blastomycosis was first described in 1902, in a case that had been misdiagnosed as a combination of tuberculosis and a blastomycosis skin infection. In 1907, the [[dimorphic fungus|dimorphic]] nature of the ''Blastomyces'' fungus was first identified.<ref name="espinelingroff1996"/> In 1912, the first case of canine blastomycosis was reported.<ref name="schwartz2018"/>

Prior to the 1930s, blastomycosis was not clearly distinguished from similar fungal conditions.<ref name="espinelingroff1996"/> A paper by [[Rhoda Williams Benham]] in 1934 distinguished the causative agent of blastomycosis from [[cryptococcosis]] and [[coccidioidomycosis]].<ref name="espinelingroff1996"/>

In the early 1950s, blastomycosis was first determined to be a primarily respiratory disease, with most skin lesions caused by systemic spread from an initial lung infection.<ref>{{Cite book
 | chapter-url = https://link.springer.com/chapter/10.1007/978-1-4757-9313-0_3
 | doi = 10.1007/978-1-4757-9313-0_3
 | title = Atlas of Infectious Diseases
 | pages = 39–51
 | chapter = Blastomycosis
 | author-first = Peter G.
 | author-last = Pappas
| year = 2000
 | isbn = 978-1-4757-9315-4
 }}</ref> In 1952, the first documented case outside North or Central America, in [[Tunisia]], was reported.<ref>{{Cite book
 | chapter-url = https://link.springer.com/chapter/10.1007/978-1-59259-296-8_29
 | doi = 10.1007/978-1-59259-296-8_29
 | title = Opportunistic Infections
 | pages = 413–427
 | chapter = Blastomyces dermatitidis
 | author-first = Vassil
 | author-last = St. Georgiev
| year = 2003
 | publisher = Humana Press
 | isbn = 9781592592968
 }}</ref> The 1950s also saw the first introduction of [[antifungal]] drugs including [[amphotericin B]].<ref name="espinelingroff1996"/> Before 1950, the fatality rate for disseminated blastomycosis was 92%, and treatment options were limited to iodide compounds, radiation therapy, and surgery.<ref name="espinelingroff1996"/> The first azole antifungal drug, [[ketoconazole]], was developed in the 1970s and approved in the United States in 1981.<ref name="espinelingroff1996"/>

Before 2013, the only species known to cause blastomycosis was ''B. dermatitidis''. Since that time, genomic analysis has identified multiple other ''Blastomyces'' species causing blastomycosis, including ''B. gilchristii'' (2013), ''B. helicus'' (reassigned from the genus ''[[Emmonsia]]'' in 2017), ''B. percursus'' (2017), and ''B. emzantsi'' (2020).<ref name="klein2021"/>

The largest-ever ''blastomycosis'' outbreak in United States history occurred at an [[Escanaba, Michigan]], paper mill in 2023. {{As of|2023|April}}, one person had died and almost a hundred more had fallen ill.<ref>{{Cite news |last=Matheny |first=Keith |date=2023-04-23 |title=As mystery of Escanaba paper mill's blastomycosis outbreak deepens, its victims try to heal |work=Detroit Free Press |url=https://www.freep.com/in-depth/news/local/michigan/2023/04/23/billeruds-escanaba-mill-blastomycosis-outbreak/70138253007/ |access-date=2023-04-23|url-access=subscription}}</ref><ref>{{Cite news |last=Tumin |first=Remy |date=2023-04-15 |title=1 Dead and Nearly 100 Sickened in Fungal Outbreak at Paper Mill |language=en-US |work=The New York Times |url=https://www.nytimes.com/2023/04/15/us/michigan-mill-blastomycosis-fungus.html |access-date=2023-04-23 |url-access=subscription}}</ref>

== Other animals ==
[[File:Jeannie dog? (82610113).jpg|thumb|The [[bluetick coonhound]] is among the dog breeds most at risk from blastomycosis.<ref name="rudmann1992"/>]]
Blastomycosis affects a broad range of [[mammal]]s. As with humans, most animals that become infected were formerly healthy and immunocompetent.<ref name="schwartz2018">{{Cite book
 | author-last = Schwartz
 | author-first = Ilan S.
 | year = 2018
 | chapter = Blastomycosis in Mammals
 | editor1 = Seyedmousavi, S.
 | editor2 = de Hoog, G.
 | editor3 = Guillot, J.
 | editor4 = Verweij, P.
 | title = Emerging and Epizootic Fungal Infections in Animals
 | pages = 159–176
 | publisher = Springer
 | doi = 10.1007/978-3-319-72093-7_8
 | isbn = 978-3-319-72093-7
| s2cid = 91080531
 }}</ref> Dogs are frequently affected; blastomycosis is eight to ten times more common in dogs than in humans.<ref name="schwartz2018"/> Sporting and [[hound]] breeds are at the greatest risk.<ref name="rudmann1992"/> Cats and horses can also be infected. Cats with [[feline immunodeficiency virus]] are particularly at risk. However, the overall risk of blastomycosis in cats is 28 to 100 times lower than in dogs.<ref name="schwartz2018"/> Cases of blastomycosis have also been reported in captive [[lion]]s and [[tiger]]s, in a wild [[North American black bear]], and in marine mammals such as the [[Atlantic bottlenose dolphin]].<ref name="schwartz2018"/>

The nonspecific symptoms that make blastomycosis difficult to diagnose in humans also complicate veterinary diagnosis. Cats, in particular, are often only diagnosed after death.<ref name="schwartz2018"/>

Dogs and humans frequently acquire blastomycosis from the same exposure event.<ref name="schwartz2018"/> In most such cases, the infection in the dog becomes apparent before the human infection.<ref name="schwartz2018"/> This may be due to a shortened incubation period, caused by the dog inhaling larger quantities of ''Blastomyces'' spores than the human.<ref name="schwartz2018"/>

In veterinary care, blastomycosis is typically treated with [[itraconazole]].<ref name="merck">{{Cite web
 | title = Blastomycosis – Generalized Conditions – Merck Veterinary Manual
 | url = https://www.merckvetmanual.com/generalized-conditions/fungal-infections/blastomycosis
 | accessdate = 2022-05-18}}</ref> 70% of treated dogs respond to medication and recover.<ref name="merck"/> In dogs as in humans, the prognosis for blastomycosis depends on the severity of the symptoms.<ref name="merck"/>

==Additional images==
<gallery mode="packed" widths="260px" heights="180">
File:North American blastomycosis 1.jpg|Granuloma with early suppuration. The fungal organisms are difficult to recognize at this low magnification.
File:North American blastomycosis 2.jpg|Large yeast-like fungi seen within giant cells at arrows.
File:North American blastomycosis 3.jpg|Large yeast-like fungi seen within giant cells at arrows. Budding yeasts in the cytoplasm of giant cells at the arrows. Broad-based budding and double-contoured cell walls are seen in the giant cell in the center are characteristic of Blastomyces dermatitidis.
File:Blastomycosis of skin.jpg|Nodular skin lesions of blastomycosis, one of which is a bullous lesion on top of a nodule.
</gallery>

== See also ==
* [[Histoplasmosis]]
* [[Paracoccidioidomycosis]]

== References ==
{{reflist|30em|refs=

<ref name=arceneaux1998>{{cite journal|last=Arceneaux|first=KA|author2=Taboada, J |author3=Hosgood, G |title=Blastomycosis in dogs: 115 cases (1980–1995).|journal=Journal of the American Veterinary Medical Association|year=1998|volume=213|issue=5|pages=658–64|doi=10.2460/javma.1998.213.05.658 |pmid=9731260}}</ref>

<ref name=archer1987>{{cite journal|last=Archer|first=JR|author2=Trainer, DO |author3=Schell, RF |title=Epidemiologic study of canine blastomycosis in Wisconsin.|journal=Journal of the American Veterinary Medical Association|year=1987|volume=190|issue=10|pages=1292–5|doi=10.2460/javma.1987.190.10.1292 |pmid=3583882}}</ref>

<ref name=armstrong1987>{{cite journal|last=Armstrong|first=CW|author2=Jenkins, SR |author3=Kaufman, L |author4=Kerkering, TM |author5=Rouse, BS |author6= Miller GB, Jr |title=Common-source outbreak of blastomycosis in hunters and their dogs.|journal=The Journal of Infectious Diseases|year=1987|volume=155|issue=3|pages=568–70|pmid=3805778|doi=10.1093/infdis/155.3.568}}</ref>

<ref name=bachir2006>{{cite journal|last=Bachir|first=J|author2=Fitch, GL|title=Northern Wisconsin married couple infected with blastomycosis.|journal=WMJ|year=2006|volume=105|issue=6|pages=55–7|pmid=17042422}}</ref>

<ref name=baumgardner1991>{{cite journal|last=Baumgardner|first=DJ|author2=Burdick, JS|title=An outbreak of human and canine blastomycosis.|journal=Reviews of Infectious Diseases|year=1991|volume=13|issue=5|pages=898–905|pmid=1962106|doi=10.1093/clinids/13.5.898}}</ref>

<ref name=baumgardner1992>{{cite journal|last=Baumgardner|first=DJ|author2=Buggy, BP |author3=Mattson, BJ |author4=Burdick, JS |author5= Ludwig, D |title=Epidemiology of blastomycosis in a region of high endemicity in north central Wisconsin.|journal=Clinical Infectious Diseases|year=1992|volume=15|issue=4|pages=629–35|pmid=1420675|doi=10.1093/clind/15.4.629}}</ref>

<ref name=baumgardner1998>{{cite journal|last=Baumgardner|first=DJ|author2=Brockman, K|title=Epidemiology of human blastomycosis in Vilas County, Wisconsin. II: 1991-1996.|journal=WMJ|year=1998|volume=97|issue=5|pages=44–7|pmid=9617309}}</ref>

<ref name=baumgardner2001>{{cite journal|last=Baumgardner|first=DJ|author2=Paretsky, DP|title=Blastomycosis: more evidence for exposure near one's domicile.|journal=WMJ|year=2001|volume=100|issue=7|pages=43–5|pmid=11816782}}</ref>

<ref name=baumgardner2002>{{cite journal|last=Baumgardner|first=DJ|author2=Egan, G |author3=Giles, S |author4= Laundre, B |title=An outbreak of blastomycosis on a United States Indian reservation.|journal=Wilderness & Environmental Medicine|year=2002|volume=13|issue=4|pages=250–2|pmid=12510781|doi=10.1580/1080-6032(2002)013[0250:aooboa]2.0.co;2}}</ref>

<ref name=baumgardner2005a>{{cite journal|last=Baumgardner|first=DJ|author2=Steber, D |author3=Glazier, R |author4=Paretsky, DP |author5=Egan, G |author6=Baumgardner, AM |author7= Prigge, D |title=Geographic information system analysis of blastomycosis in northern Wisconsin, USA: waterways and soil.|journal=Medical Mycology |year=2005|volume=43|issue=2|pages=117–25|pmid=15832555|doi=10.1080/13693780410001731529|doi-access=free}}</ref>

<ref name=baumgardner2006>{{cite journal|last=Baumgardner|first=DJ|author2=Knavel, EM |author3=Steber, D |author4= Swain, GR |title=Geographic distribution of human blastomycosis cases in Milwaukee, Wisconsin, USA: association with urban watersheds.|journal=Mycopathologia|year=2006|volume=161|issue=5|pages=275–82|pmid=16649077|doi=10.1007/s11046-006-0018-9|s2cid=7953521}}</ref>

<ref name=blondin2007>{{cite journal|last=Blondin|first=N|author2=Baumgardner, DJ |author3=Moore, GE |author4= Glickman, LT |title=Blastomycosis in indoor cats: suburban Chicago, Illinois, USA.|journal=Mycopathologia|year=2007|volume=163|issue=2|pages=59–66|pmid=17262169|doi=10.1007/s11046-006-0090-1|s2cid=1227756}}</ref>

<ref name=cano2003>{{cite journal|last=Cano|first=MV|author2=Ponce-de-Leon, GF |author3=Tippen, S |author4=Lindsley, MD |author5=Warwick, M |author6= Hajjeh, RA |title=Blastomycosis in Missouri: epidemiology and risk factors for endemic disease.|journal=Epidemiology and Infection|year=2003|volume=131|issue=2|pages=907–14|pmid=14596532|doi=10.1017/s0950268803008987|pmc=2870035}}</ref>

<ref name=chapman1997>{{cite journal|last=Chapman|first=SW|author2=Lin, AC |author3=Hendricks, KA |author4=Nolan, RL |author5=Currier, MM |author6=Morris, KR |author7= Turner, HR |title=Endemic blastomycosis in Mississippi: epidemiological and clinical studies.|journal=Seminars in Respiratory Infections|year=1997|volume=12|issue=3|pages=219–28|pmid=9313293}}</ref>

<ref name=crampton2002>{{cite journal|last=Crampton|first=TL|author2=Light, RB |author3=Berg, GM |author4=Meyers, MP |author5=Schroeder, GC |author6=Hershfield, ES |author7= Embil, JM |title=Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitals.|journal=Clinical Infectious Diseases|year=2002|volume=34|issue=10|pages=1310–6|pmid=11981725|doi=10.1086/340049|doi-access=free}}</ref>

<ref name=degroote2000>{{cite journal|last=De Groote|first=MA|author2=Bjerke, R |author3=Smith, H |author4= Rhodes III, LV |title=Expanding epidemiology of blastomycosis: clinical features and investigation of 2 cases in Colorado.|journal=Clinical Infectious Diseases|year=2000|volume=30|issue=3|pages=582–4|pmid=10722448|doi=10.1086/313717|doi-access=free}}</ref>

<ref name=disalvo1992>{{cite book|last=DiSalvo|first=A.F.|title=Ecology of Blastomyces dermatitidis|year=1992|publisher=Plenum|pages=43–73|author-link=Blastomycosis|editor=Al-Doory, Y. |editor2=DiSalvo, A.F.}}</ref>

<ref name=dwight2000>{{cite journal|last=Dwight|first=P.J.|author2=Naus, M |author3=Sarsfield, P |author4= Limerick, B |title=An outbreak of human blastomycosis: the epidemiology of blastomycosis in the Kenora catchment region of Ontario, Canada.|journal=Canada Communicable Disease Report|year=2000|volume=26|issue=10|pages=82–91|pmid=10893821}}</ref>

<ref name=dworkin2005>{{cite journal|last=Dworkin|first=MS|author2=Duckro, AN |author3=Proia, L |author4=Semel, JD |author5= Huhn, G |title=The epidemiology of blastomycosis in Illinois and factors associated with death.|journal=Clinical Infectious Diseases|year=2005|volume=41|issue=12|pages=e107–11|pmid=16288388|doi=10.1086/498152|doi-access=free}}</ref>

<ref name=kane1983>{{cite journal|last=Kane|first=J|author2=Righter, J |author3=Krajden, S |author4= Lester, RS |title=Blastomycosis: a new endemic focus in Canada.|journal=Canadian Medical Association Journal|year=1983|volume=129|issue=7|pages=728–31|pmid=6616383|pmc=1875443}}</ref>

<ref name=kepron1972>{{cite journal|last=Kepron|first=MW|author2=Schoemperlen  |author3=Hershfield, ES |author4=Zylak, CJ |author5= Cherniack, RM |title=North American blastomycosis in Central Canada. A review of 36 cases.|journal=Canadian Medical Association Journal|year=1972|volume=106|issue=3|pages=243–6|pmid=5057959|pmc=1940364}}</ref>

<ref name=kesselman2005>{{cite journal|last=Kesselman|first=EW|author2=Moore, S |author3=Embil, JM |title=Using local epidemiology to make a difficult diagnosis: a case of blastomycosis.|journal=CJEM|year=2005|volume=7|issue=3|pages=171–3|pmid=17355674|doi=10.1017/S1481803500013221|doi-access=free}}</ref>

<ref name=kitchen1977>{{cite journal|last=Kitchen|first=MS|author2=Reiber, CD |author3=Eastin, GB |title=An urban epidemic of North American blastomycosis.|journal=The American Review of Respiratory Disease|year=1977|volume=115|issue=6|pages=1063–6|pmid=262101|doi=10.1164/arrd.1977.115.6.1063|doi-broken-date=11 July 2025|url=https://www.atsjournals.org/doi/abs/10.1164/arrd.1977.115.6.1063|url-access=subscription}}</ref>

<ref name=klein1987>{{cite journal|last=Klein|first=Bruce S.|author2=Vergeront, James M. |author3=Weeks, Robert J. |author4=Kumar, U. Nanda |author5=Mathai, George |author6=Varkey, Basil |author7=Kaufman, Leo |author8=Bradsher, Robert W. |author9=Stoebig, James F. |author10= Davis, Jeffrey P. |title=Isolation of Blastomyces dermatitidis in Soil Associated with a Large Outbreak of Blastomycosis in Wisconsin|journal=New England Journal of Medicine|year=1986|volume=314|issue=9|pages=529–534|doi=10.1056/NEJM198602273140901 |pmid=3945290}}</ref>

<ref name=kwonchung1992>{{cite book|last1=Kwon-Chung|first1=K.J.|last2=Bennett|first2=J.E.|title=Medical mycology|year=1992|publisher=Lea & Febiger|location=Philadelphia|isbn=978-0812114638}}{{page number needed|date=December 2024}}</ref>

<ref name=lemos2000>{{cite journal|last=Lemos|first=LB|author2=Guo, M |author3=Baliga, M |title=Blastomycosis: organ involvement and etiologic diagnosis. A review of 123 patients from Mississippi.|journal=Annals of Diagnostic Pathology|year=2000|volume=4|issue=6|pages=391–406|pmid=11149972|doi=10.1053/adpa.2000.20755}}</ref>

<ref name=lester2000>{{cite journal|last=Lester|first=RS|author2=DeKoven, JG |author3=Kane, J |author4=Simor, AE |author5=Krajden, S |author6= Summerbell, RC |title=Novel cases of blastomycosis acquired in Toronto, Ontario.|journal=CMAJ: Canadian Medical Association Journal|year=2000|volume=163|issue=10|pages=1309–12|pmid=11107469|pmc=80342}}</ref>

<ref name=lowry1989>{{cite journal|last=Lowry|first=PW|author2=Kelso, KY |author3=McFarland, LM |title=Blastomycosis in Washington Parish, Louisiana, 1976–1985.|journal=American Journal of Epidemiology|year=1989|volume=130|issue=1|pages=151–9|pmid=2787106|doi=10.1093/oxfordjournals.aje.a115307}}</ref>

<ref name=manetti1991>{{cite journal|last=Manetti|first=AC|title=Hyperendemic urban blastomycosis.|journal=American Journal of Public Health|year=1991|volume=81|issue=5|pages=633–6|pmid=2014867|doi=10.2105/ajph.81.5.633|pmc=1405080}}</ref>

<ref name=mmwr1996>{{cite journal |title=Blastomycosis--Wisconsin, 1986-1995 |journal=MMWR Morb. Mortal. Wkly. Rep. |volume=45 |issue=28 |pages=601–3 |year=1996 |pmid=8676851 |author1= Centers for Disease Control and Prevention (CDC)}}</ref>

<ref name=morris2006>{{cite journal|last=Morris|first=SK|author2=Brophy, J |author3=Richardson, SE |author4=Summerbell, R |author5=Parkin, PC |author6=Jamieson, F |author7=Limerick, B |author8=Wiebe, L |author9= Ford-Jones, EL  |title=Blastomycosis in Ontario, 1994–2003.|journal=Emerging Infectious Diseases|year=2006|volume=12|issue=2|pages=274–9|pmid=16494754|doi=10.3201/eid1202.050849|pmc=3373107}}</ref>

<ref name=proctor2002>{{cite journal|last=Proctor|first=ME|author2=Klein, BS |author3=Jones, JM |author4= Davis, JP |title=Cluster of pulmonary blastomycosis in a rural community: evidence for multiple high-risk environmental foci following a sustained period of diminished precipitation.|journal=Mycopathologia|year=2002|volume=153|issue=3|pages=113–20|pmid=11998870|doi=10.1023/A:1014515230994|s2cid=38668503}}</ref>

<ref name=renston1992>{{cite journal|last=Renston|first=JP|author2=Morgan, J |author3=DiMarco, AF |title=Disseminated miliary blastomycosis leading to acute respiratory failure in an urban setting.|journal=Chest|year=1992|volume=101|issue=5|pages=1463–5|pmid=1582324|doi=10.1378/chest.101.5.1463}}</ref>

<ref name=rippon1988>{{cite book|last=Rippon|first=John Willard|title=Medical mycology : the pathogenic fungi and the pathogenic actinomycetes|year=1988|publisher=W.B. Saunders Co.|location=Philadelphia|isbn=9780721624440|edition=3rd}}</ref>

<ref name=rudmann1992>{{cite journal|last=Rudmann|first=DG|author2=Coolman, BR |author3=Perez, CM |author4= Glickman, LT |title=Evaluation of risk factors for blastomycosis in dogs: 857 cases (1980-1990)|journal=Journal of the American Veterinary Medical Association|year=1992|volume=201|issue=11|pages=1754–9|doi=10.2460/javma.1992.201.11.1754 |pmid=1293122}}</ref>

<ref name=sekhon1982>{{cite journal|last=Sekhon|first=AS|author2=Jackson, FL |author3=Jacobs, HJ |title=Blastomycosis: report of the first case from Alberta Canada.|journal=Mycopathologia|year=1982|volume=79|issue=2|pages=65–9|pmid=6813742|doi=10.1007/bf00468081|s2cid=27296444}}</ref>

<ref name=vaaler1990>{{cite journal|last=Vaaler|first=AK|author2=Bradsher, RW |author3=Davies, SF |title=Evidence of subclinical blastomycosis in forestry workers in northern Minnesota and northern Wisconsin.|journal=The American Journal of Medicine|year=1990|volume=89|issue=4|pages=470–6|pmid=2220880|doi=10.1016/0002-9343(90)90378-q}}</ref>

<ref name=vallabh1988>{{cite journal|last=Vallabh|first=V|author2=Martin, T |author3=Conly, JM |title=Blastomycosis in Saskatchewan.|journal=The Western Journal of Medicine|year=1988|volume=148|issue=4|pages=460–2|pmid=3388850|pmc=1026149}}</ref>

<ref name=vasquez1998>{{cite journal|last=Vasquez|first=JE|author2=Mehta, JB |author3=Agrawal, R |author4= Sarubbi, FA |title=Blastomycosis in northeast Tennessee.|journal=Chest|year=1998|volume=114|issue=2|pages=436–43|pmid=9726727|doi=10.1378/chest.114.2.436}}</ref>

<ref name=veligandla2002>{{cite journal |vauthors=Veligandla SR, Hinrichs SH, Rupp ME, Lien EA, Neff JR, Iwen PC |title=Delayed diagnosis of osseous blastomycosis in two patients following environmental exposure in nonendemic areas |journal=Am. J. Clin. Pathol. |volume=118 |issue=4 |pages=536–41 |date=October 2002 |pmid=12375640 |doi=10.1309/JEJ0-3N98-C3G8-21DE |doi-access=free }}</ref>

}}

== Further reading ==
* {{cite journal |vauthors=Castillo CG, Kauffman CA, Miceli MH| title=Blastomycosis | journal=Infectious Disease Clinics of North America | volume=30 |issue=1 | pages=247–264 | pmid=26739607 | doi=10.1016/j.idc.2015.10.002| year=2016 }} (Review).
* {{cite journal |vauthors=McBride JA, Gauthier GM, Klein BS | title=Clinical Manifestations and Treatment of Blastomycosis | journal=Clinics in Chest Medicine | volume=38 |issue=3 | pages=435–449 | pmid=28797487 | pmc=5657236 | doi=10.1016/j.ccm.2017.04.006| year=2017 }} (Review)
* {{Cite news |last=Jacobs |first=Becky|date=2023-04-26|title=A rare fungal infection broke out at a paper mill. Here's what to know about blastomycosis in Wisconsin. |url=https://www.postcrescent.com/story/news/2023/04/26/wisconsin-monitors-blastomycosis-outbreak-at-escanaba-paper-mill/70131097007/ |access-date=2024-12-07|newspaper=The Post-Crescent |location=Appleton, Wisconsin |language=en-US}}

== External links ==
{{Medical resources
|   ICD10       = {{ICD10|B|40||b|35}}
|   ICD9        = {{ICD9|116.0}}
|   DiseasesDB     = 1439
|   ICDO           =
|   OMIM           =
|   MedlinePlus    = 000102
|   eMedicineSubj  = med
|   eMedicineTopic = 231
|   eMedicine_mult = {{eMedicine2|ped|254}}
|   MeshID         = D001759
}}
* {{Commons category-inline}}
* {{MeshName|Blastomyces}}
* [https://www.medlineplus.gov/ency/article/000102.htm NIH Encyclopedia Blastomycosis]

{{Mycoses|state=collapsed}}

[[Category:Animal fungal diseases]]
[[Category:Mycosis-related cutaneous conditions]]
[[Category:Fungal diseases]]